Article Figures & Data
Tables
Patient no. Indication 131I dose (MBq) Delay (h)* Measured dose rate (μSv/h) < 2.5† Surface activity (Bq/cm2) < 5† Activity (Bq) < 1,000,000† 1 Graves’ disease 740 17 6 13.7 69,171 2 Graves’ disease 740 113 0.20 0.80 2,478 3 Multinodular goiter 1,110 89 1.50 1.60 22,166 4 Graves’ disease 1,850 17 2.30 2.30 38,380 5 Multinodular goiter 1,850 41 <0.01 1.20 4,314 6 Thyroid carcinoma 3,700 17 0.28 1.42 51,157 7 Thyroid carcinoma 3,700 41 2.60 1.20 51,966 8 Thyroid carcinoma 3,700 41 1.30 1.60 11,971 9 Thyroid carcinoma 3,700 41 1.30 1.60 13,617 10 Thyroid carcinoma 3,700 41 1.50 1.10 17,321 11 Thyroid carcinoma 3,700 41 1.50 2.10 12,949 12 Thyroid carcinoma 3,700 44 1.20 1.80 34,340 13 Thyroid carcinoma 3,700 89 1.50 2.20 27,594 14 Thyroid carcinoma 3,700 113 1.00 0.28 8,032 15 Thyroid carcinoma 3,700 113 1.30 1.50 11,315